Page last updated: 2024-12-08

glucosylsucrose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

glucosylsucrose: principle constituent of coupling sugar which is prepared from starch & sucrose; similar taste to cane sugar [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

erlose : A trisaccharide consisting of sucrose having an alpha-D-glucopyranosyl residue attached at the 4-position of the glucose ring. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID193471
CHEBI ID55512
SCHEMBL ID935091
MeSH IDM0086829

Synonyms (25)

Synonym
beta-d-fructofuranosyl alpha-d-glucopyranosyl-(1->4)-alpha-d-glucopyranoside
CHEBI:55512
sucrosylglucose
glucosylsucrose
erlose
13101-54-7
(2r,3r,4s,5s,6r)-2-[(2r,3s,4r,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
alpha-d-glucopyranoside, beta-d-fructofuranosyl o-alpha-d-glucopyranosyl-(1-4)-
unii-c3uyo172pu
c3uyo172pu ,
SCHEMBL935091
W-201046
alpha-maltosyl beta-fructofuranoside
fructomaltose
DTXSID10927037
Q3056700
fructofuranoside, o-.alpha.-d-glucopyranosyl-(1->4)-.alpha.-d-glucopyranosyl, .beta.-d-
(2r,3r,4s,5s,6r)-2-((2r,3s,4r,5r,6r)-6-((2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yloxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2h-pyran-3-yloxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
F82969
alpha-d-glc-(1->4)-alpha-d-glc-(1->2)-beta-d-fru
a-d-glucopyranoside,b-d-fructofuranosyl o-a-d-glucopyranosyl-(1(r)4)-
CS-0198511
HY-139338
AKOS040756633
fructofuranoside, o-?-d-glucopyranosyl-(1?4)-?-d-glucopyranosyl, ?-d- (7ci); fructofuranoside, ?-maltosyl, ?-d- (6ci); glucopyranoside, ?-d-fructofuranosyl 4-o-?-d-glucopyranosyl-, ?-d- (8ci); ?-d-fructofuranosyl o-?-d-glucopyranosyl-(1?4)-?-d-glucopyrano
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
trisaccharide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (20.00)18.7374
1990's2 (20.00)18.2507
2000's2 (20.00)29.6817
2010's3 (30.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.33 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]